基于菌体的疫苗:一种新的预防和治疗策略
Sharareh Mohammad Hasani1, Elham Ghafouri1, Shirin Kouhpayeh2
1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Heliyon
|October 9, 2023
概括
菌体为疫苗开发提供了一种新的方法,刺激强大的免疫反应,并使口服管理成为可能. 本综述探讨了用于疾病预防和治疗的菌体疫苗的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 爱德华·詹纳1796年的天花疫苗标志着医学科学的革命.
- 有效的疫苗依赖于主导性免疫表位,以获得强大的免疫反应.
- 细菌体因其在疫苗设计中的潜力而越来越被认可.
研究的目的:
- 审查细菌基疫苗的当前改进情况.
- 探索以菌体为基础的疫苗作为预防或治疗剂的应用.
主要方法:
- 本综述综合了关于菌体在疫苗开发中的应用现有研究.
- 对免疫刺激和疫苗输送相关的菌体属性的分析.
主要成果:
- 菌体对人类是非传染性的,并且不结合细胞受体.
- 菌体可以激活细胞和幽默免疫,作为有效的辅助剂.
- 基于菌体的疫苗由于胃肠道稳定性而提供口服.
结论:
- 菌体技术为现代疫苗开发提供了显著的优势.
- 基于菌体的疫苗显示出对预防和治疗应用的前景.
相关概念视频
Lytic Cycle of Bacteriophages
70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
Cancer Vaccines
389
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
389
Microorganisms in Medicine and Therapeutics
37
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
37
DNA Bacteriophages
29
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
29
Lysogenic Cycle of Bacteriophages
62.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.3K
Viral Replication: Lysogenic Cycle
33
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
33


